EVALUATION OF DOMICILIARY TREATMENT WITH TERBUTALINE BY WET NEBULISATION IN PATIENTS WITH CHRONIC BRONCHITIS AND EMPHYSEMA

Australian and New Zealand Journal of Medicine

Volumn 15, Issue 2, 1985, Pages 230-234

  SILINS, R A ^a   MARLIN, G E ^a  

^a Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

bronchodilator; chronic bronchitis; domiciliary treatment; emphysema; Terbutaline; wet nebulisation

Indexed keywords

BECLOMETASONE DIPROPIONATE; IPRATROPIUM BROMIDE; PLACEBO; PREDNISONE; TERBUTALINE; THEOPHYLLINE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DRUG THERAPY; FORCED EXPIRATORY VOLUME; HOME CARE; HUMAN; NEBULIZATION; RESPIRATORY SYSTEM; THERAPY;

AEROSOLS; AGED; BRONCHITIS; CHRONIC DISEASE; CLINICAL TRIALS; DOUBLE-BLIND METHOD; HOME CARE SERVICES; HUMAN; MALE; MIDDLE AGE; PULMONARY EMPHYSEMA; RANDOM ALLOCATION; RESPIRATORY FUNCTION TESTS; TERBUTALINE;

EID: 0021853376     PISSN: 00048291     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1985.tb04014.x     Document Type: Article

References (13)

1. Patient error in use of bronchodilator metered aerosols
2. Use of pressurised aerosol by asthmatic patients
3. The adequacy of inhalation of aerosol from canister nebulizers
4. Optimum delivery of aerosols from metered dose inhalers
5. Comparison of wet and dry aerosol salbutamol
6. Comparison of terbutaline by aerosolised solution and metered pressurised aerosol in patients with chronic bronchitis and emphysema
7. Domiciliary nebulised salbutamol solution in severe chronic airway obstruction
8. The assessment of airflow obstruction. Role of measurement of airway resistance and tests of forced expiration
9. Smoking, airflow limitation and the pulmonary circulation
10. Bronchial responsiveness to inhaled histamine and isoprenaline in patients with airways obstruction
11. The effects of salbutamol aerosol on lung function in patients with pulmonary emphysema
12. Lung distehsibility. The static pressure‐volume curve of the lungs and its use in clinical assessment
13. The fate of nebulised salbutamol (Albuterol) administered by intermittent positive pressure respiration to asthmatic patients